Ethical issues in the neonatal patient with end-stage renal disease.
While treatment for the neonate continues to be challenging, current technical advances offer more options. Before the 1980s chronic dialysis was technically so difficult for neonates and infants that most considered it impossible; in the 1990s renal replacement therapy is a viable choice. The purpose of this article is neither to advocate active intervention nor passive supportive care, but to help the reader consider questions frequently faced when deciding what to do for a neonate with end-stage renal disease (ESRD). Today ethical issues are tied closely to health care reform, so this bioethical dilemma has only begun. As health care reform addresses benefits of care, the bioethical dilemmas raised by neonates with ESRD will need to carefully considered.
Currier
H
H
D001675:Bioethics; D002651:Child Advocacy; D006801:Humans; D007231:Infant, Newborn; D007676:Kidney Failure, Chronic / Q000628:therapy*; D008297:Male; D011788:Quality of Life; D017582:Renal Replacement Therapy